Skip to main content

Table 4 DNA (%) presented in “head” and “ tail ” pre- and post-incubation with doxorubicin in breast cancer cell lines

From: Use of the comet assay technique for quick and reliable prediction of in vitro response to chemotherapeutics in breast and colon cancer

  Control Doxorubicin (1 μM)
  % DNA % DNA % DNA % DNA
(mean ± 1.96 S.E.) (mean ± 1.96 S.E.) (mean ± 1.96 S.E.) (mean ± 1.96 S.E.)
  in Head in Tail in Head in Tail
MCF-7 66.43 ± 3.68 33.56 ± 3.68 81.33 ± 2.67 19.17 ± 2.62
MDA-MB 231 77.14 ± 2.98 22.85 ± 2.98 83.93 ± 1.94 16.06 ± 1.94
T47D 77.87 ± 2.60 22.12 ± 2.60 83.17 ± 2.27 16.82 ± 2.27